You are using an older browser version. Please use a supported version for the best MSN experience.

We're bring back these psychedelic drugs, 'but as a medical treatment against various forms of mental health issues': atai Life Sciences Founder

Christian Angermayer, atai Life Sciences Founder & Chairman, joined Yahoo Finance Live to break down atai's public debut on the Nasdaq and the future of the psychedelic sector.

UP NEXT

UP NEXT

image beaconimage beaconimage beacon